Elsevier is a leader in information and analytics helping researchers and healthcare professionals advance science and improve health outcomes for the benefit of society.
As one of the world’s fastest growing access publishers, Elsevier enables open access in nearly all its 2,700+ journals, with 600+ dedicated open access journals.
Further information on this agreement is available from Elsevier.
This page was last updated on 30 July 2024.
The following institutions participate in this agreement:
* These institutions have access to only selected titles. Please refer to the Elsevier Journal Finder for further details.
Authors who do not see their institution listed above should contact library staff to enquire further.
This agreement allows authors from participating institutions to publish in most of Elsevier's hybrid journals without the need for any transactional open access article processing charge (APC).
This is a capped agreement. This agreement provides for an allowance of 10,440 articles by authors from institutions participating in the agreement to be published open access in 2024 with no transactional APCs.
Authors publishing in Elsevier's hybrid journals can utilize the APC Quota and publishing in Gold OA only titles can utilize a discount.
Articles accepted from 1/1/2024 are eligible to be published open access under this agreement.
The following article types are eligible for open access under this agreement:
As defined by the publisher, the eligible author is:
The corresponding author is the person who submits the manuscript and other related documentation to the journal and is the primary contact between the journal and all other authors. If the paper is published, the corresponding author is also the first point of contact for readers.
Responsible corresponding authors must include a participating institution as one of their affiliations to benefit from this agreement.
Authors will be identified as eligible for open access publishing by their:
Responsible corresponding authors must use their institutional email address when submitting an article for publication.
Responsible corresponding authors should not use personal email addresses (e.g. Hotmail, Gmail). Doing so may result in delayed approval of the article or the article may not be approved to be published open access under the terms of the agreement.
Articles not covered by this agreement may benefit from a 15% discount on eligible APCs. Please consult the title list for eligible journals.
Discounts exist for gold open-access journals not covered by the Quota.
The discount will be automatically presented to authors who are publishing in eligible titles.
The agreement allows for publishing in most journals. If you wish to publish open access, please check to ensure that your desired journal is included.
The title list is dynamic and will change throughout the year. To check for a title or search by subject area please use this website.
Hybrid journals that 'flip' to OA during the course of this agreement may be eligible for OA publishing. If a journal flips to OA, authors should check with the publisher if they will be charged an APC.
On 29 July 2024, the agreement was amended as follows:
If a core hybrid journal that is also an Eligible Journal converts to fully gold open access during the Initial Term, such journal will remain an Eligible Journal under this Agreement. Please note this only applies to articles accepted from 9-Aug-2024 onwards.
Articles from authors at participating institutions may be published under the following Creative Commons licenses:
Some or all exclusive rights are assigned to the publisher.
Please see here for Elsevier's OA licence policies.
Further information about licenses is available on the publisher's website.
The Creative Commons licenses allow reuse (some with conditions) while protecting the authors' rights of acknowledgment as authors.
Article approvals are managed by CAUL via a custom publisher platform.
Elsevier does charge additional fees for page and/or colour fees. Authors should always check each journal’s submission guidelines to ensure that they will not be subject to any other fees or charges.
The following instructions for authors have been provided by the publisher. Further details are available on the publisher’s website.
1.Follow Elsevier's usual article submission process via https://www.elsevier.com/authors/submit-your-paper
2.On acceptance of the article, the Elsevier will ask the corresponding author to make their publishing choices and complete a form (publishing agreement).
3.The corresponding author selects open access and confirms the licence type (e.g. CC-BY).
The APC is automatically waived for authors who have declared their affiliation to a participating CAUL institution during the publishing workflow
Example screenshot(s):
Please email oasupport@elsevier.com for questions regarding this agreement. Please include your full name, institution, article title, journal name and DOI (if available), and state the reason for your enquiry.
Please email consortium@caul.edu.au for questions regarding this agreement. Please include your full name, institution, article title, journal name and DOI (if available), and state the reason for your enquiry.
